Arkin Bio-Ventures Overview
- Founded
-
2016
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
- Investments
-
16
Arkin Bio-Ventures General Information
Description
Provider of investment services to companies that develop pharmaceuticals. The company identifies, invests in and accompanies innovative early and mid-stage companies in areas such as immunotherapy, cancer, metabolism, microbiome, CNS, autoimmune diseases, orphan diseases and drug delivery platforms.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Private Equity
Primary Office
- Israel
Arkin Bio-Ventures Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Arkin Bio-Ventures Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Pini Orbach Ph.D | Head of Pharma |
Arkin Bio-Ventures Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Arkin Bio-Ventures Investments (16)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 0000000 | 20-Jul-2022 | 00000 0000 | 0000 | Drug Discovery | |
| 000000 | 01-May-2022 | 00000 0000 | 0000 | Drug Discovery | |
| 00000000 0000 | 24-Dec-2020 | 00000 0000 | 0000 | Drug Discovery | |
| 00000 0000000 | 16-Dec-2020 | 0000 00000 | 000.00 | Drug Discovery | |
| BioSight | 02-Dec-2020 | Later Stage VC | 0000 | Drug Discovery | 0000 0000 |
Arkin Bio-Ventures Exits (5)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000000 | 20-Dec-2019 | 00000 00000 00 | 000.00 | Completed |
|
| 00 000000000000 | 29-May-2019 | 00000 00000 00 | 000.00 | Completed |
|
| 00000000 | 04-Jan-2017 | 00000 00000 00 | 00.00 | Completed |
|
| 0000000 | 15-Dec-2016 | 00000 00000 00 | 000.00 | Completed |
|
| Oncorus | 19-Jul-2016 | Early Stage VC | 000.00 | Completed |
|